loadpatents
name:-0.020823001861572
name:-0.0083911418914795
name:-0.0047588348388672
HIRAOKA; Shogo Patent Filings

HIRAOKA; Shogo

Patent Applications and Registrations

Patent applications and USPTO patent grants for HIRAOKA; Shogo.The latest application filed is for "freeze-dried aripiprazole formulation".

Company Profile
4.15.18
  • HIRAOKA; Shogo - Osaka JP
  • Hiraoka; Shogo - Osaka-shi JP
  • Hiraoka; Shogo - Tokushima-ken JP
  • - Tokushima JP
  • Hiraoka; Shogo - Tokushima N/A JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Freeze-dried Aripiprazole Formulation
App 20220008341 - HIRAOKA; Shogo
2022-01-13
Freeze-dried aripiprazole formulation
Grant 11,154,507 - Hiraoka October 26, 2
2021-10-26
Methods For Producing Aripiprazole Suspension And Freeze-dried Formulation
App 20200246333 - Kind Code
2020-08-06
Dual Chamber Prefillable Syringe And Aripiprazole Filled In Syringe
App 20200155764 - KAKIUCHI; Makoto ;   et al.
2020-05-21
Microspheres having core/shell structure
Grant 10,632,079 - Hiraoka
2020-04-28
Methods For Producing Aripiprazole Suspension And Freeze-dried Formulation
App 20180185358 - Hiraoka; Shogo ;   et al.
2018-07-05
Suspension And Cake Composition Containing Carbostyryl Derivative And Silicone Oil And/or Silicone Oil Derivative
App 20170112830 - Hiraoka; Shogo
2017-04-27
Methods For Producing Aripiprazole Suspension And Freeze-dried Formulation
App 20170035752 - Hiraoka; Shogo ;   et al.
2017-02-09
Aqueous ophthalmic suspension of crystalline rebamipide
Grant 9,533,052 - Matsuda , et al. January 3, 2
2017-01-03
Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative
Grant 9,511,022 - Hiraoka December 6, 2
2016-12-06
Methods for producing aripiprazole suspension and freeze-dried formulation
Grant 9,457,026 - Hiraoka , et al. October 4, 2
2016-10-04
Aqueous Ophthalmic Suspension Of Crystalline Rebamipide
App 20160101183 - MATSUDA; Takakuni ;   et al.
2016-04-14
Aqueous ophthalmic suspension of crystalline rebamipide
Grant 9,211,254 - Matsuda , et al. December 15, 2
2015-12-15
Medical syringe
Grant D741,476 - Hiraoka , et al. October 20, 2
2015-10-20
Medical syringe
Grant D729,931 - Takeuchi , et al. May 19, 2
2015-05-19
Freeze-dried Aripiprazole Formulation
App 20140112993 - Hiraoka; Shogo
2014-04-24
Dual Chamber Prefillable Syringe And Aripiprazole Filled In Syringe
App 20140005610 - Kakiuchi; Makoto ;   et al.
2014-01-02
Hydrogel suspension and manufacturing process thereof
Grant 08617606 -
2013-12-31
Hydrogel suspension and manufacturing process thereof
Grant 8,617,606 - Hiraoka , et al. December 31, 2
2013-12-31
Medical Device Containing A Cake Composition Comprising Aripiprazole As An Active Ingredient, And A Cake Composition Comprising Aripiprazole As An Active Ingredient
App 20130302384 - Hiraoka; Shogo ;   et al.
2013-11-14
Suspension And Cake Composition Containing Carbostyryl Derivative And Silicone Oil And/or Silicone Oil Derivative
App 20130045250 - Hiraoka; Shogo
2013-02-21
Microspheres Having Core/shell Structure
App 20100203151 - Hiraoka; Shogo
2010-08-12
Methods For Producing Aripiprazole Suspension And Freeze-dried Formulation
App 20100196486 - Hiraoka; Shogo ;   et al.
2010-08-05
Hydrogel Suspension and Manufacturing Process Thereof
App 20090148529 - Hiraoka; Shogo ;   et al.
2009-06-11
Aqueous Ophthalmic Suspension of Crystalline Rebamipide
App 20070287729 - Matsuda; Takakuni ;   et al.
2007-12-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed